DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
01.09.2022 22:15:00
|
Dexcom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences:
- Wells Fargo 2022 Healthcare Conference on Wednesday, September 7, 2022 at 2:35pm (EST).
- Baird 2022 Global Healthcare Conference on Wednesday, September 14, 2022 at 8:30am (EST).
Links to the webcasts will be available on the DexCom Investor Relations website at investors.dexcom.com and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220901005807/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
02.05.25 |
Gewinne in New York: Schlussendlich Pluszeichen im NASDAQ 100 (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: NASDAQ Composite zum Handelsende mit Zuschlägen (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: S&P 500 liegt letztendlich im Plus (finanzen.at) | |
02.05.25 |
Gute Stimmung in New York: So steht der NASDAQ Composite am Nachmittag (finanzen.at) | |
02.05.25 |
Gewinne in New York: Das macht der S&P 500 am Nachmittag (finanzen.at) | |
02.05.25 |
Pluszeichen in New York: NASDAQ 100 klettert nachmittags (finanzen.at) | |
02.05.25 |
Börse New York: Am Mittag Pluszeichen im NASDAQ Composite (finanzen.at) | |
02.05.25 |
Handel in New York: S&P 500 notiert am Mittag im Plus (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 64,14 | 2,71% |
|